Humacyte HUMA
NASDAQ HUMA
$0.51 -0.01 (-1.99%)
As of: Oct 1, 2026 · 9:53 AM EDT

Humacyte (HUMA) Long-Term Debt Issuances (2020 - 2025)

Updated

Humacyte (HUMA) reported Long-Term Debt Issuances of $175,000 for Q4 2025.

Analysis

Humacyte (HUMA) Long-Term Debt Issuances (2020 - 2025) Analysis & Trends

Dating back to Q3 2020, Humacyte's Long-Term Debt Issuances record includes 6 quarters.

  • Long-Term Debt Issuances has a five-year compound annual growth rate of -44.3% (FY2020 to FY2025).
  • By year, Long-Term Debt Issuances came in at $20 million in FY2024 (-49.2%), $39.38 million in FY2023 and $29.66 million in FY2021 (+812.3%).
  • The Q4 2025 figure ranks as the highest quarterly Long-Term Debt Issuances since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Humacyte 144.46 Mn 144.46 Mn -825,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 175,000.00
Mar 31, 2024 20.00 Mn
Jun 30, 2023 39.38 Mn
Dec 31, 2021 10.00 Mn
Mar 31, 2021 19.66 Mn
Sep 30, 2020 89,076.00
API Access

Humacyte Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=HUMA&period=max&api_key=YOUR_API_KEY